Breaking News
Get 50% Off 0
💎 Bargain Hunter: Undervalued stocks with massive upside potential
Get the list

IDEXX Laboratories stock price target raised to $785 from $625 at Jefferies

Published Aug 05, 2025 13:18
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
IDXX
-2.77%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Investing.com - Jefferies has raised its price target on IDEXX Laboratories (NASDAQ:IDXX) to $785.00 from $625.00 while maintaining a Buy rating on the stock. The new target comes as IDEXX trades near its 52-week high of $688.12, having delivered an impressive 65% return year-to-date according to InvestingPro data.

The price target increase follows what Jefferies described as "strong" second-quarter results for IDEXX, which showed sales growth of 10.6% and EBITDA growth of 14%. The company maintains robust profitability with a 61.5% gross margin and strong return on equity of 65%.

IDEXX management has also raised guidance for the company, which Jefferies interprets as confirmation that "the innovation playbook is working."

Jefferies noted that IDEXX's decision to accelerate spending in several markets signals confidence in expected returns and supports the high single-digit percentage growth outlook despite challenging macroeconomic conditions.

The firm believes these factors, combined with a predictable growth reacceleration as the pandemic cohort ages, justify a premium valuation for IDEXX Laboratories stock.

In other recent news, IDEXX Laboratories Inc. reported impressive financial results for the second quarter of 2025. The company significantly exceeded earnings and revenue forecasts, posting an earnings per share (EPS) of $3.63, which surpassed the expected $3.29. This marks a 17% increase on a comparable basis. Revenue for the quarter reached $1.11 billion, surpassing the forecast of $1.06 billion. These results highlight IDEXX Laboratories' strong performance and financial health. There were no recent reports of mergers involving the company. Analyst notes and upgrades or downgrades were not mentioned in the recent updates. Investors may find these developments noteworthy as they assess IDEXX Laboratories' market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

IDEXX Laboratories stock price target raised to $785 from $625 at Jefferies
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email